RE: Rhambo16 Dec 2014 23:07
Hello Sidam,
I thought their CAPEX/cost justification is particularly clumsy. They state net ouflow of £15.2m and justify it by saying:
- £8.2m CAPEX - fine, nothing unusual
- £10.7 operational capital movements
THen you think ah, £18.9m that explains it, but then tacked on is the £6.5m royalty drawdown which reduces op capital exp to £4.2, so that's only at £12.6m outflow. There are obviously other cashflow pressures therefore that are pushing this into the red by some £2.6m or so.
Yet, there is £9m loss on operating profit, with £62m going on R&D. Where's the money come from for this? I'm not sure it's realised revenue, it's stayed static year on year which suggests to me a static accrual of licence income and WIP rather than realised revenue. Source of the cash? The original £38 mil placement, a small proportion of licence fees and overdraft facilities (which we already know from this RNS is the main source of cash reserve).
I'll be damned if there's not a placing here in the next couple of months.